TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Neuropathic Pain With Spinal Cord Stimulation and Physiotherapy for More Effective Pain Relief, Increased Physical Activity and Improved Health Related Quality of Life
Brief Summary: The study evaluates the combined effect of optimized pharmacological treatment, spinal cord stimulation and physiotherapy on pain relief, health-related quality of life and physical function in patients with neuropathic pain. All patients will receive optimized pharmacological treatment before start of spinal cord stimulation treatment. Half of the participants will be randomized to physiotherapy before start of spinal cord stimulation treatment while the other half will start physiotherapy after spinal cord stimulation treatment.


Options:
A: Arm Label: Spinal Cord Stimulation (SCS); Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Other: Physiotherapy | Arm Label: Physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal Cord Stimulation (SCS), Other: Physiotherapy | Intervention Type: DEVICE; Name: Spinal Cord Stimulation (SCS); Assigned to Arm(s): Physiotherapy, Spinal Cord Stimulation (SCS) | Intervention Type: OTHER; Name: Physiotherapy; Assigned to Arm(s): Physiotherapy, Spinal Cord Stimulation (SCS)
B: Arm Label: High Frequency; Type: EXPERIMENTAL; Interventions: Device: Spinal Cord Stimulator HF | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Spinal Cord Stimulator Sham | Intervention Type: DEVICE; Name: Spinal Cord Stimulator HF; Assigned to Arm(s): High Frequency | Intervention Type: DEVICE; Name: Spinal Cord Stimulator Sham; Assigned to Arm(s): Sham
C: Arm Label: Burst SCS; Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation, Device: SCS implant | Arm Label: Sham SCS; Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation, Device: SCS implant | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst SCS, Sham SCS | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst SCS, Sham SCS | Intervention Type: DEVICE; Name: SCS implant; Assigned to Arm(s): Burst SCS, Sham SCS
D: Arm Label: Group A - active treatment; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation by implanted device. | Arm Label: Group B - conservative management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Spinal cord stimulation by implanted device.; Assigned to Arm(s): Group A - active treatment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating the Cloud DX Platform as a Tool for Self-management and Asynchronous Remote-monitoring of Chronic Obstructive Pulmonary Disease
Brief Summary: This study is an open-label, prospective, single-centre, randomized controlled trial, containing both a quantitative and a qualitative component and using a mixed-methods design. The study evaluates the impact of Cloud Dx kit, a device that can allows patients to monitor and manage Chronic Obstructive Pulmonary Disease (COPD) at their home. The study evaluates whether using Cloud Dx improves patients' COPD symptoms, ability to manage COPD, and quality of life.

It is anticipated that there will be 123 participants enrolled in this study across two experimental arms and one control arm. Participants will be in the study for 6 months and the study will run for 1 year a Markham-Stouffville Hospital. The primary outcome is the participants' self-management and activation which will be measured using The Partners in Health (PIH) scale, a validated scale measuring the current status of self-management, with items on knowledge of the condition and skills to monitor and respond to symptoms.


Options:
A: Arm Label: Remote-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with remote-monitoring | Arm Label: Self-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with self-monitoring | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cloud Dx Kit with self-monitoring; Assigned to Arm(s): Self-Monitoring Program | Intervention Type: DEVICE; Name: Cloud Dx Kit with remote-monitoring; Assigned to Arm(s): Remote-Monitoring Program
B: Arm Label: Intercom; Type: EXPERIMENTAL; Interventions: Other: INTERdisciplinary COMmunity-based COPD management (INTERCOM) | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: INTERdisciplinary COMmunity-based COPD management (INTERCOM); Assigned to Arm(s): Intercom
C: Arm Label: Control period; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemonitoring; Type: EXPERIMENTAL; Interventions: Device: CE marked Philips Motiva system | Intervention Type: DEVICE; Name: CE marked Philips Motiva system; Assigned to Arm(s): Telemonitoring
D: Intervention Type: BEHAVIORAL; Name: Internet-based Dyspnea Self-Management Program; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face Dyspnea Self-Management Program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating the Cloud DX Platform as a Tool for Self-management and Asynchronous Remote-monitoring of Chronic Obstructive Pulmonary Disease
Brief Summary: This study is an open-label, prospective, single-centre, randomized controlled trial, containing both a quantitative and a qualitative component and using a mixed-methods design. The study evaluates the impact of Cloud Dx kit, a device that can allows patients to monitor and manage Chronic Obstructive Pulmonary Disease (COPD) at their home. The study evaluates whether using Cloud Dx improves patients' COPD symptoms, ability to manage COPD, and quality of life.

It is anticipated that there will be 123 participants enrolled in this study across two experimental arms and one control arm. Participants will be in the study for 6 months and the study will run for 1 year a Markham-Stouffville Hospital. The primary outcome is the participants' self-management and activation which will be measured using The Partners in Health (PIH) scale, a validated scale measuring the current status of self-management, with items on knowledge of the condition and skills to monitor and respond to symptoms.


Options:
A: Arm Label: Remote-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with remote-monitoring | Arm Label: Self-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with self-monitoring | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cloud Dx Kit with self-monitoring; Assigned to Arm(s): Self-Monitoring Program | Intervention Type: DEVICE; Name: Cloud Dx Kit with remote-monitoring; Assigned to Arm(s): Remote-Monitoring Program
B: Arm Label: Telemedicine; Type: ACTIVE_COMPARATOR; Interventions: Device: Telemedicine | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telemedicine; Assigned to Arm(s): Telemedicine
C: Arm Label: COPD Telehealth Program; Type: EXPERIMENTAL; Interventions: Behavioral: Telehealth Program | Intervention Type: BEHAVIORAL; Name: Telehealth Program; Assigned to Arm(s): COPD Telehealth Program
D: Arm Label: 1 Intervention group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supported self management training and support | Arm Label: 2; Type: NO_INTERVENTION; Interventions: Behavioral: Supported self management training and support | Intervention Type: BEHAVIORAL; Name: Supported self management training and support; Assigned to Arm(s): 1 Intervention group, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating the Cloud DX Platform as a Tool for Self-management and Asynchronous Remote-monitoring of Chronic Obstructive Pulmonary Disease
Brief Summary: This study is an open-label, prospective, single-centre, randomized controlled trial, containing both a quantitative and a qualitative component and using a mixed-methods design. The study evaluates the impact of Cloud Dx kit, a device that can allows patients to monitor and manage Chronic Obstructive Pulmonary Disease (COPD) at their home. The study evaluates whether using Cloud Dx improves patients' COPD symptoms, ability to manage COPD, and quality of life.

It is anticipated that there will be 123 participants enrolled in this study across two experimental arms and one control arm. Participants will be in the study for 6 months and the study will run for 1 year a Markham-Stouffville Hospital. The primary outcome is the participants' self-management and activation which will be measured using The Partners in Health (PIH) scale, a validated scale measuring the current status of self-management, with items on knowledge of the condition and skills to monitor and respond to symptoms.


Options:
A: Arm Label: COPD Telehealth Program; Type: EXPERIMENTAL; Interventions: Behavioral: Telehealth Program | Intervention Type: BEHAVIORAL; Name: Telehealth Program; Assigned to Arm(s): COPD Telehealth Program
B: Arm Label: Activity-Self Management; Type: EXPERIMENTAL; Interventions: Behavioral: Self-Management and Motivational Interviewing | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-Management and Motivational Interviewing; Assigned to Arm(s): Activity-Self Management
C: Arm Label: Urban training Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Urban training | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Urban training; Assigned to Arm(s): Urban training Intervention
D: Arm Label: Remote-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with remote-monitoring | Arm Label: Self-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with self-monitoring | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cloud Dx Kit with self-monitoring; Assigned to Arm(s): Self-Monitoring Program | Intervention Type: DEVICE; Name: Cloud Dx Kit with remote-monitoring; Assigned to Arm(s): Remote-Monitoring Program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Rehabilitation of Postural Abnormalities in Parkinson's Disease: a Single-blind, Randomised Controlled Trial
Brief Summary: Postural abnormalities (PA) are drug refractory complications in patients with Parkinson's disease (PD) leading to pain, imbalance, gait disorders and fall-related injuries. It ultimately affects the quality of life and the hospitalisation risk. the literature on treatment outcomes is scant. Rehabilitation is the cornerstone in the management of PD patients, especially for drug-refractory complications. However, the current efforts are only partially able to resolve PA in PD. Despite differences in methodologies, the few rehabilitative studies support the benefits of trunk rehabilitation in PD with PA. Priorities for future research include well-design rehabilitation studies on a large population. The early detection and early rehabilitation of PA might avoid fixed irreversible deformities and reduce the complications that can accompany them. It ultimately might improve the quality of life, reduce the risk of fall-related injuries and hospitalisation rate. A single-blind single-blind Randomised Controlled Trial (RCT) will evaluate the effects of trunk rehabilitation on PA severity, function and disability in outpatients with Parkinson Disease and postural abnormalities.


Options:
A: Arm Label: CVT-301 Low Dose; Type: EXPERIMENTAL; Interventions: Drug: CVT-301 Low Dose | Arm Label: CVT-301 High Dose; Type: EXPERIMENTAL; Interventions: Drug: CVT-301 High Dose | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: CVT-301 Low Dose; Assigned to Arm(s): CVT-301 Low Dose | Intervention Type: DRUG; Name: CVT-301 High Dose; Assigned to Arm(s): CVT-301 High Dose | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Procedure: Experimental group | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Experimental group; Assigned to Arm(s): Experimental | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control
C: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: ParkNet | Arm Label: II; Type: OTHER; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: ParkNet; Assigned to Arm(s): I | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): II
D: Arm Label: ADS-5102; Type: EXPERIMENTAL; Interventions: Drug: ADS-5102 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: ADS-5102; Assigned to Arm(s): ADS-5102 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Dumbbell Exercise on Arteriovenous Fistula in Patients With Hemodialysis：A Prospective Randomized,Controlled Trial
Brief Summary: Isometric exercise has been shown to increase the diameter and the blood flow rate of forearm veins.At present, more studies focus on the perioperative period to promote the maturation of arteriovenous fistula(AVF), while there are few reports on functional maintenance measures for the patients with maintenance hemodialysis.This study aims to explore the effect of dumbbell exercise on AVF，and evaluate whether patients can carry a 6-pound item with the fistula limb in a reasonable way.


Options:
A: Arm Label: Repetitive handgrip exercise; Type: EXPERIMENTAL; Interventions: Other: Repetitive arm exercise | Arm Label: No arm exercise; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Repetitive arm exercise; Assigned to Arm(s): Repetitive handgrip exercise
B: Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Hand Exercise | Intervention Type: BEHAVIORAL; Name: Hand Exercise; Assigned to Arm(s): Exercise Arm
C: Arm Label: The handgrip exercise; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: The handgrip exercise | Arm Label: The dumbbell exercise; Type: EXPERIMENTAL; Interventions: Behavioral: The dumbbell exercise | Intervention Type: BEHAVIORAL; Name: The handgrip exercise; Assigned to Arm(s): The handgrip exercise | Intervention Type: BEHAVIORAL; Name: The dumbbell exercise; Assigned to Arm(s): The dumbbell exercise
D: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: experimental group | Arm Label: Group control; Type: SHAM_COMPARATOR; Interventions: Other: experimental group | Intervention Type: OTHER; Name: experimental group; Assigned to Arm(s): Experimental group, Group control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nasopharyngeal Airway Facilitate Transnasal Humidified Rapid Insufflation Ventilatory Exchange
Brief Summary: For performing transnasal humidified rapid insufflation ventilatory exchange (THRIVE), jaw-thrust maneuver have to maintain to make sure the airway open and the CO2 clearance during apnoea. The objective of present study is to prove that nasopharyngeal airway facilitate THRIVE and no need jaw-thrust maneuver and maintain the similar PO2 and PCO2 during apnoea.


Options:
A: Arm Label: Nasal high-flow oxygen therapy; Type: EXPERIMENTAL; Interventions: Device: Optiflow (Fisher & Paykel Healthcare) | Arm Label: Venturi mask oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Venturi mask | Intervention Type: DEVICE; Name: Optiflow (Fisher & Paykel Healthcare); Assigned to Arm(s): Nasal high-flow oxygen therapy | Intervention Type: DEVICE; Name: Venturi mask; Assigned to Arm(s): Venturi mask oxygen therapy
B: Arm Label: High flow oxygen delivery; Type: EXPERIMENTAL; Interventions: Device: High flow nasal cannula oxygen delivery | Arm Label: Low Flow oxygen delivery; Type: EXPERIMENTAL; Interventions: Device: Low flow nasal cannula oxygen delivery | Arm Label: Standard practice of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: High flow nasal cannula oxygen delivery; Assigned to Arm(s): High flow oxygen delivery | Intervention Type: DEVICE; Name: Low flow nasal cannula oxygen delivery; Assigned to Arm(s): Low Flow oxygen delivery
C: Arm Label: THRIVE; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: THRIVE with nasopharyngeal airway; Type: ACTIVE_COMPARATOR; Interventions: Device: Nasopharyngeal airway | Intervention Type: DEVICE; Name: Nasopharyngeal airway; Assigned to Arm(s): THRIVE with nasopharyngeal airway
D: Arm Label: VL and AO; Type: ACTIVE_COMPARATOR; Interventions: Device: Apneic Oxygenation, Device: No Apneic Oxygenation | Arm Label: DL and AO; Type: ACTIVE_COMPARATOR; Interventions: Device: Apneic Oxygenation, Device: No Apneic Oxygenation | Arm Label: VL and no AO; Type: ACTIVE_COMPARATOR; Interventions: Device: Video Laryngoscopy, Device: Direct Laryngoscopy | Arm Label: DL and no AO; Type: ACTIVE_COMPARATOR; Interventions: Device: Video Laryngoscopy, Device: Direct Laryngoscopy | Intervention Type: DEVICE; Name: Video Laryngoscopy; Assigned to Arm(s): DL and no AO, VL and no AO | Intervention Type: DEVICE; Name: Apneic Oxygenation; Assigned to Arm(s): DL and AO, VL and AO | Intervention Type: DEVICE; Name: Direct Laryngoscopy; Assigned to Arm(s): DL and no AO, VL and no AO | Intervention Type: DEVICE; Name: No Apneic Oxygenation; Assigned to Arm(s): DL and AO, VL and AO

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
Brief Summary: This is an open-label, multicenter, Phase 2 study to determine the safety, PK, and efficacy of lisocabtagene maraleucel (JCAR017) in subjects who have relapsed from, or are refractory to, two lines of immunochemotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) in the outpatient setting. Subjects will receive treatment with JCAR017 and will be followed for up to 2 years.


Options:
A: Arm Label: Lisocabtagene maraleucel; Type: EXPERIMENTAL; Interventions: Biological: lisocabtagene maraleucel | Intervention Type: BIOLOGICAL; Name: lisocabtagene maraleucel; Assigned to Arm(s): Lisocabtagene maraleucel
B: Arm Label: Axicabtagene Ciloleucel and Rituximab Combination; Type: EXPERIMENTAL; Interventions: Biological: Axicabtagene Ciloleucel, Drug: Rituximab, Drug: Fludarabine, Drug: Cyclophosphamide | Intervention Type: BIOLOGICAL; Name: Axicabtagene Ciloleucel; Assigned to Arm(s): Axicabtagene Ciloleucel and Rituximab Combination | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Axicabtagene Ciloleucel and Rituximab Combination | Intervention Type: DRUG; Name: Fludarabine; Assigned to Arm(s): Axicabtagene Ciloleucel and Rituximab Combination | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Axicabtagene Ciloleucel and Rituximab Combination
C: Arm Label: huCART19; Type: EXPERIMENTAL; Interventions: Biological: huCART19 | Intervention Type: BIOLOGICAL; Name: huCART19; Assigned to Arm(s): huCART19
D: Arm Label: Arm A - Standard of Care (SOC); Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard of Care | Arm Label: Arm B - JCAR017; Type: EXPERIMENTAL; Interventions: Genetic: JCAR017 | Intervention Type: DRUG; Name: Standard of Care; Assigned to Arm(s): Arm A - Standard of Care (SOC) | Intervention Type: GENETIC; Name: JCAR017; Assigned to Arm(s): Arm B - JCAR017

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect Of Erector Spinae Plane Block On Postoperative Pain Management In Lumbar Disc Hernia Repair Operation
Brief Summary: Pain management after lomber disc hernia repair surgery is a challenging issue for anesthetists. Erector Spinae plane block is a novel analgesic technique which could be used for this purpose. Primary aim of this double blinded randomized controlled study is to compare the analgesic efficacy of this new block technique with control group in this group of patients.


Options:
A: Arm Label: Erector Spinae Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Erector Spinae Plane Block - Ultrasound guided | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Erector Spinae Plane Block - Ultrasound guided; Assigned to Arm(s): Erector Spinae Plane Block
B: Arm Label: Erector Spinae Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: regional anaesthesia with Levobupivicaine 0.25% 30mls with two methods either erector spinae plane block or serratus anterior plane block | Arm Label: Serratus Anterior Plane Block; Type: EXPERIMENTAL; Interventions: Procedure: regional anaesthesia with Levobupivicaine 0.25% 30mls with two methods either erector spinae plane block or serratus anterior plane block | Intervention Type: PROCEDURE; Name: regional anaesthesia with Levobupivicaine 0.25% 30mls with two methods either erector spinae plane block or serratus anterior plane block; Assigned to Arm(s): Erector Spinae Plane Block, Serratus Anterior Plane Block
C: Arm Label: Erector Spinae Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Erector Spinae Plane block, Drug: Bupivacaine Hydrochloride, Device: PCA | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham block, Device: PCA | Intervention Type: PROCEDURE; Name: Erector Spinae Plane block; Assigned to Arm(s): Erector Spinae Plane Block | Intervention Type: PROCEDURE; Name: Sham block; Assigned to Arm(s): Control Group | Intervention Type: DRUG; Name: Bupivacaine Hydrochloride; Assigned to Arm(s): Erector Spinae Plane Block | Intervention Type: DEVICE; Name: PCA; Assigned to Arm(s): Control Group, Erector Spinae Plane Block
D: Arm Label: erector spinae block; Type: EXPERIMENTAL; Interventions: Procedure: erector spinae block | Arm Label: serratus anterior block; Type: EXPERIMENTAL; Interventions: Procedure: serratus plane block | Arm Label: intravenous morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine Sulfate | Intervention Type: PROCEDURE; Name: serratus plane block; Assigned to Arm(s): serratus anterior block | Intervention Type: PROCEDURE; Name: erector spinae block; Assigned to Arm(s): erector spinae block | Intervention Type: DRUG; Name: Morphine Sulfate; Assigned to Arm(s): intravenous morphine

Answer: C